Literature DB >> 12131200

Ritonavir-associated hyperparathyroidism, osteopenia and bone pain.

Peter J Piliero, Andrew G Gianoukakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12131200     DOI： 10.1097/00002030-200207260-00019

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

1.  Increased risk of fragility fractures among HIV infected compared to uninfected male veterans.

Authors:  Julie A Womack; Joseph L Goulet; Cynthia Gibert; Cynthia Brandt; Chung Chou Chang; Barbara Gulanski; Liana Fraenkel; Kristin Mattocks; David Rimland; Maria C Rodriguez-Barradas; Janet Tate; Michael T Yin; Amy C Justice
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

2.  WNT/beta-catenin signaling is involved in regulation of osteoclast differentiation by human immunodeficiency virus protease inhibitor ritonavir: relationship to human immunodeficiency virus-linked bone mineral loss.

Authors:  Rozbeh Modarresi; Zhaoying Xiang; Michael Yin; Jeffrey Laurence
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

3.  Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study.

Authors:  Eric Bonnet; Jean-Bernard Ruidavets; Anne Genoux; Laurence Mabile; Florian Busato; Martine Obadia; François Prévoteau; Bruno Marchou; Patrice Massip; Fabrice Marion-Latard; Cyrille Delpierre; Jacques Bernard; Bertrand Perret
Journal:  BMC Infect Dis       Date:  2013-06-28       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.